Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Hepatocellular 9Stomach Neoplasms 3Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Gastric Adenocarcinoma 2Advanced Gastric Cancer 2Thymic epithelial tumor 1Solid Tumor 1Sarcoma 1Pancreatic Neoplasms 1Ovarian Cancer Recurrent 1Neuroendocrine Tumors 1Locally Advanced Gastric Cancer 1Liver Neoplasms 1Liposarcoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

liposomal doxorubicin 1camrelizumab 1apatinib 1X-Rays 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Liposarcoma × apatinib × Clear all
NCT06694324 2024-11-19

First-line Treatment of Advanced/unresectable DDLPS

Fudan University

Phase 2 Not yet recruiting
49 enrolled
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡